Pulse nav.journalClub Debates activos Tendencias Explorar Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

© Synapse Social LLC, 2026

Política de privacidad

Inicio Explorar nav.journalClub Tendencias

⌘+K

Patient Expectancy as a Mediator of Placebo Effects in Antidepressant Clinical Trials | Synapse

September 9, 2016Open Access

Patient Expectancy as a Mediator of Placebo Effects in Antidepressant Clinical Trials

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Patient expectancy is a significant mediator of placebo effects in antidepressant trials. Expectancy-related interventions should be investigated as a means of controlling placebo responses in antidepressant clinical trials and improving patient outcome in clinical treatment.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Rutherford et al. (Fri,) studied this question.

synapsesocial.com/papers/69d9a0aec7f0c3ae80a3e0e3 https://doi.org/https://doi.org/10.1176/appi.ajp.2016.16020225

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1A randomized, prospective pilot study of patient expectancy and antidepressant outcome2012 · 43 citations
2Efficacy of applied relaxation and cognitive-behavioral therapy in the treatment of generalized anxiety disorder.1993 · 633 citations
3Efficacy of applied relaxation and cognitive-behavioral therapy in the treatment of generalized anxiety disorder.1993 · 562 citations
4Citalopram versus fluoxetine: a double-blind, controlled, multicentre, phase III trial in patients with unipolar major depression treated in general practice1996 · 85 citations
5Diagnostic and Statistical Manual of Mental Disorders.2000 · 19,848 citations